KANATIVA USA INC. sold 20.8% of their position (5M shares) of NEXIEN BIOPHARMA, INC. on the open market
Open‑market sale worth $425.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/1/2019ACC: 0001144204-19-023075
-5M
Net shares
Net seller
$425.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5M
Price / share
$0.09
Trade value
$425K
% of position
20.8%
4/4/2019
24M→19M
Total
Net shares
−5M
Net value
-$425K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/4/2019 | S · Sale | −5M | $0.09 | $425K | 20.8% | 24M | 19M |
| Total | −5M | -$425K | ||||||
Derivative Transactions0
No derivative transactions reported